Dr. Lyon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Burlington, VT 05401Phone+1 802-847-4237
Education & Training
- University of Vermont Medical CenterResidency, Internal Medicine, 2002 - 2005
- University of Vermont College of MedicineClass of 2002
Certifications & Licensure
- VT State Medical License 2002 - 2024
Clinical Trials
- Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Start of enrollment: 2010 Jan 01
- A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047 Start of enrollment: 2017 May 01
Publications & Presentations
PubMed
- 146 citationsRobust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healt...Beth D. Kirkpatrick, Anna P. Durbin, Kristen K. Pierce, Marya P. Carmolli, Cecilia M. Tibery
The Journal of Infectious Diseases. 2015-09-01 - 22 citationsOutcomes and adverse events among patients with implantable cardiac defibrillators in cardiac rehabilitation: a case-controlled study.Sarah Fan, Caroline E. Lyon, Patrick D. Savage, Al Ozonoff, Philip A. Ades
Journal of Cardiopulmonary Rehabilitation and Prevention. 2009-01-01 - 29 citationsLack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.Beth D. Kirkpatrick, Caroline E. Lyon, Chad K. Porter, Alex C. Maue, Patricia Guerry
Clinical Infectious Diseases. 2013-10-15
Press Mentions
- UVM Researchers Test First-Ever Cholera VaccineJune 15th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: